Bryan Garnier - Fielmann (FIE) Fielmann: unlocking margin potential

Report

Bryan Garnier

Cedric Rossi

Fielmann: unlocking margin potential

The stronger-than-expected margin delivery in FY24 unveiled yesterday has two positive outcomes: 1/ Fielmann USA demonstrated its capacity to improve profitability while maintaining a strong operating performance (+11% LFL) and 2/ it lends greater credibility to its reiterated FY25 aEBITDA margin t

05/03/2025 1 EN

Underlying

Fielmann

See profile

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Cedric Rossi

Other Reports on these Companies

Bryan Garnier

US eyewear: Trumping tariffs

With existing duties relatively low compared to other consumer categories, the potential new tariffs that could be imposed by incoming President Trump are naturally sparking concern across the US optical industry. At this stage, we are optimistic about the sector's ability to navigate tariffs: (i)

February 10, 2025 February 10, 2025 1 EN

Bryan Garnier

On the shelves now: Consumer Weekly #53

In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. Happy reading!

January 13, 2025 January 13, 2025 1 EN

adidas: we are not worried by ADS' prudent margin outlook for 2025

Definitive 2024 results released this morning are in line with the stronger-than-expected numbers pre-released on 22nd January. As a reminder, Q4 sales showed a 12% beat, while EBIT came in at EUR57m versus the CSSe at -EUR62m. All eyes are now on the FY25 outlook: we are not surprised by the relat

19h / 51m 19h / 51m 1 EN

Oscar Haffen Lamm

Oscar Haffen Lamm

Egetis: KOL event takeaways

Egetis hosted a KOL event with Prof. Edward Visser, from the Erasmus MC, which focused on the advancements in MCT8 deficient patient identification in the past years largely due to increased disease awareness and the widespread availability of genetic panels — which have led to a greater number of

19h / 54m 19h / 54m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Fielmann: unlocking margin potential

US eyewear: Trumping tariffs

On the shelves now: Consumer Weekly #53

adidas: we are not worried by ADS' prudent margin outlook for 2025

Egetis: KOL event takeaways

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe